Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 4 3Phase 3 3Phase NA 2Phase 1/2 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2

Conditions

Seizures 2Brain Neoplasms 2Postoperative Seizures After Brain Tumor Surgery 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Levetiracetam × Clear all
NCT07239115 2026-05-28

PREVENT

Beijing Tiantan Hospital

Phase 3 Recruiting
558 enrolled

Postoperative Seizures After Brain Tumor Surgery

NCT06442748 2026-02-13

LIBRA

Tata Memorial Centre

Phase 3 Recruiting
604 enrolled
CNS

Brain Neoplasms, Seizures

NCT05897658 2024-10-23

LeviTaTe Pilot

Hamilton Health Sciences Corporation

Phase 3 Not yet recruiting
70 enrolled
CNS

Brain Neoplasms, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡